Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
Authors:
- L De MarcoLML De Marco
- M MazzuccatoMMM Mazzuccato
- M Grazia Del BenMBM Grazia Del Ben
- U BuddeUBU Budde
- A B FedericiAFA B Federici
- A GirolamiAGA Girolami
- Z M RuggeriZRZ M Ruggeri
Open Access
- 1 August 1987
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 80 (2) , 475-482
Abstract
Three preparations of purified von Willebrand factor (vWF), obtained from unrelated patients affected by type IIB von Willebrand disease, were found to have normal sialic acid content (between 129 and 170 nmol/mg of vWF, as compared with 158 +/- 17 nmol/mg in four normal preparations) and to induce platelet aggregation in the presence of physiologic levels of divalent cations and without addition of ristocetin. A monoclonal antibody that blocks the vWF binding domain of the platelet glycoprotein (GP)Ib caused complete inhibition of IIB vWF-induced aggregation. In contrast, a monoclonal antibody that blocks the receptor for adhesive proteins on the platelet GPIIb/IIIa complex failed to inhibit the initial response of platelets to high concentrations of IIB vWF. Moreover, IIB vWF caused agglutination of formalin-fixed platelets that was blocked only by the anti-GPIb antibody, suggesting that the binding of vWF to GPIb, even in the absence of ristocetin, results in platelet-platelet interaction that is followed by exposure of the GPIIb/IIIa receptors for adhesive proteins. Endogenous ADP, normally active platelet metabolism and fibrinogen binding to GPIIb/IIIa were necessary for maximal and irreversible platelet aggregation. In the absence of fibrinogen, however, aggregation was mediated by vWF binding to GPIIb/IIIa. A 52/48-kD tryptic fragment containing the GPIb binding domain of normal vWF completely blocked the aggregation induced by all three IIB vWF preparations. The present study defines in detail the mechanisms involved in IIB vWF-induced platelet aggregation. Moreover, it establishes that the GPIb binding domain of normal and IIB vWF are closely related and that desialylation is not required for the direct interaction of IIB vWF with GPIb.Keywords
This publication has 38 references indexed in Scilit:
- Cycles of Agglutination-Disagglutination Induced by Ristocetin in Thrombasthenic PlateletsBritish Journal of Haematology, 1979
- Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-SepharoseImmunochemistry, 1978
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- FACTOR-VIII-RELATED PROPERTIES IN PLATELETS FROM PATIENTS WITH VONWILLEBRANDS DISEASE1978
- Dysfibrinogenemia Associated with Liver DiseaseJournal of Clinical Investigation, 1977
- MECHANISMS OF PLATELET SHAPE CHANGE, AGGREGATION, AND RELEASE INDUCED BY COLLAGEN, THROMBIN, OR A23,1871977
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)Thrombosis and Haemostasis, 1975
- Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2Nature New Biology, 1973
- Evidence for Linkage of Univalent Fragments or Half-Molecules of Rabbit γ-Globulin by the Same Disulfide Bond*Biochemistry, 1964